Snapshot from Jun 25, 2026 at 22:38 UTC. For live data and tracking: View Live
Person

Outi Vaarala

Tracked across 1 events · 6 articles · First seen May 21, 2026 · Last active May 30, 2026

Sentiment
60
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
4 60
Tech
Orion announced the first clinical data from its Phase 1/2 TEADES trial for ODM-212, an investigational oral pan-TEAD inhibitor, at the 2026 American Society of Clinical Oncology Annual Meeting. The results indicated that ODM-212 was…
Impact: Outi Vaarala, Executive Vice President of Research & Development at Orion, expressed encouragement regarding the safety profile and early clinical activity of ODM-212.
May 21, 2026 · 6 articles
NEWSDESK
Track Outi Vaarala live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.